Upregulation and activation of Stat6 precede vascular smooth muscle cell proliferation in carotid artery injury model.
The role of signal transducers and activators of transcription (STAT) proteins in modulating proliferation and differentiation of various cell types in the hematopoietic system and the central nervous system has been well established. In contrast, the pathophysiological role of these proteins in vascular proliferative diseases has remained unproven, despite in vitro observations emphasizing the involvement of the STAT system in mediating vascular smooth muscle cell (VSMC) proliferation. On the basis of our previous observations demonstrating the occurrence of a specific modulation of Stat6 protein during the proliferative, migratory, and differentiation phases of the developing brain, we investigated whether Stat6 protein is present and modulated in arterial tissue challenged by perivascular injury. The time course of expression and localization of Stat6 after arterial injury was analyzed by immunohistochemistry, Western blot analysis, and confocal microscopy. Six hours after injury, the expression of Stat6 was markedly increased. This overexpression preceded the onset of VSMC proliferation and was downregulated starting from 7 days after injury, coincident with the decline of VSMC proliferation. Moreover, early after injury, Stat6 was predominantly localized at the nuclear level, denoting its functional activation. Conversely, Stat6 staining at later time points was largely cytosolic, suggesting silencing effects of this signaling pathway. These data indicate that Stat6 signaling may contribute to the modifications of gene expression underlying VSMC activation in the context of acute vascular proliferative diseases.
Baetta
R
R
Institute of Pharmacological Sciences, University of Milan, Milan, Italy. Roberta.Baetta@unimi.it
Soma
M
M
De-Fraja
C
C
Comparato
C
C
Teruzzi
C
C
Magrassi
L
L
Cattaneo
E
E
D000818:Animals; D001692:Biological Transport; D015153:Blotting, Western; D002339:Carotid Arteries / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D020212:Carotid Artery Injuries / Q000378:metabolism / Q000473:pathology*; D002455:Cell Division; D002467:Cell Nucleus / Q000378:metabolism; D002478:Cells, Cultured; D007150:Immunohistochemistry; D007700:Kinetics; D008297:Male; D018613:Microscopy, Confocal; D009131:Muscle, Smooth, Vascular / Q000473:pathology*; D011817:Rabbits; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000032:analysis; D018123:Receptors, Interleukin / Q000032:analysis; D053660:Receptors, Interleukin-13; D019948:Receptors, Interleukin-4 / Q000032:analysis; D050800:STAT6 Transcription Factor; D015534:Trans-Activators / Q000032:analysis / Q000502:physiology*
D018123:Receptors, Interleukin; D053660:Receptors, Interleukin-13; D019948:Receptors, Interleukin-4; D050800:STAT6 Transcription Factor; D015534:Trans-Activators; D020797:Receptor, Platelet-Derived Growth Factor beta